ETF profile for iShares Genomics Immunology And Healthcare ETF (IDNA) from the issuer: top holdings, net assets, expense ratio and shares outstanding.
IDNA ETF Profile
| Family: |
Blackrock (iShares) |
| Name: |
iShares Genomics Immunology and Healthcare ETF |
|
|
| Inception Date: |
11-Jun-2019 |
| Termination Date: |
|
| Investment Objective: |
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering. |
|
|
| Prospectus |
|
|
|
| Top 10 Holdings |
|
|
| MODERNA |
MRNA |
12.2113% |
| TWIST BIOSCIENCE |
TWST |
5.5952% |
| IOVANCE BIOTHERAPEUTICS INC |
IOVA |
4.9242% |
| GENMAB |
GMAB |
4.6131% |
| TAKEDA PHARMACEUTICAL |
4502 |
3.7508% |
| REGENERON PHARMACEUTICALS |
REGN |
3.6853% |
| REVOLUTION MEDICINES |
RVMD |
3.5960% |
| EXELIXIS INC |
EXEL |
3.5412% |
| MERCK & CO INC |
MRK |
3.4866% |
| CARIS LIFE SCIENCES |
CAI |
3.4859% |
|
Top 10 Holdings Weight: |
48.9% |
| Number of Holdings: |
65 |
| Shares Outstanding: |
7,800,000 |
| Total Net Assets: |
320,112,000 |
| NAV: |
41.06 |
| Net Expense Ratio: |
0.47% |
|
|
| Asset Class: |
Equities (Stocks) |
| Developed or Emerging: |
Developed Market Funds |
| Country: |
|
| Region: |
|
| Strategy: |
|
| Currency: |
|
| Commodity: |
|
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Dividend Type: |
|
| Tax Exempt State: |
|
| Maturity Duration: |
|
| Market Cap: |
Broad Market / Multi-Cap |
| Credit Quality: |
|
| Mortgage Bond Types: |
|
| Bond Type: |
|
| Gov't Bond Types: |
|
| Reit Type: |
|
| Leverage Direction/Factor: |
|
| Is Currency Hedged: |
No |
| US or Ex-US: |
Global |
